|
|
|
Insider
Information: |
Shah Preetam |
Relationship: |
CFO & CBO |
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
347,560 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$6,357 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
347,560 |
|
|
Total
Value |
$6,357 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
|
|
Stock
price went down : |
|
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Brainstorm Cell Therapeutics Inc |
BCLI |
EVP, CFO and Treasurer |
2020-12-30 |
11,600 |
2019-09-06 |
0 |
Premium* |
|
Cidara Therapeutics, Inc. |
CDTX |
CFO & CBO |
2024-03-15 |
335,960 |
2021-11-12 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
12 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CDTX |
Cidara Therapeutics, Inc. |
CFO & CBO |
|
2024-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
108,750 |
335,960 |
0 |
- |
|
CDTX |
Cidara Therapeutics, Inc. |
CFO & CBO |
|
2024-03-11 |
4 |
S |
$0.67 |
$12,680 |
D/D |
(18,931) |
227,210 |
0 |
- |
|
CDTX |
Cidara Therapeutics, Inc. |
CFO & CBO |
|
2023-03-27 |
4 |
A |
$0.00 |
$0 |
D/D |
90,000 |
238,141 |
0 |
- |
|
CDTX |
Cidara Therapeutics, Inc. |
CFO & CBO |
|
2023-03-13 |
4 |
S |
$1.53 |
$10,171 |
D/D |
(6,648) |
148,141 |
0 |
- |
|
CDTX |
Cidara Therapeutics, Inc. |
CFO & CBO |
|
2022-09-19 |
4 |
S |
$0.77 |
$12,035 |
D/D |
(15,642) |
150,789 |
0 |
- |
|
CDTX |
Cidara Therapeutics, Inc. |
CFO & CBO |
|
2022-09-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
50,000 |
166,431 |
0 |
- |
|
CDTX |
Cidara Therapeutics, Inc. |
CFO & CBO |
|
2022-03-31 |
4 |
D |
$0.83 |
$20,601 |
D/D |
(24,820) |
112,431 |
0 |
- |
|
CDTX |
Cidara Therapeutics, Inc. |
CFO & CBO |
|
2022-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
117,251 |
137,251 |
0 |
- |
|
CDTX |
Cidara Therapeutics, Inc. |
CFO & CBO |
|
2021-11-12 |
4 |
B |
$1.54 |
$30,800 |
D/D |
20,000 |
20,000 |
2.74 |
- |
|
BCLI |
Brainstorm Cell Therapeut... |
EVP, CFO and Treasurer |
|
2020-12-30 |
4 |
D |
$4.64 |
$116,000 |
D/D |
(25,000) |
11,600 |
0 |
- |
|
BCLI |
Brainstorm Cell Therapeut... |
EVP, CFO and Treasurer |
|
2019-12-24 |
4 |
B |
$3.96 |
$45,929 |
D/D |
11,600 |
36,600 |
2.74 |
- |
|
BCLI |
Brainstorm Cell Therapeut... |
EVP, CFO and Treasurer |
|
2019-09-06 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
25,000 |
0 |
- |
|
12 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|